cover image: Initial treatment of community-acquired pneumonia

Premium

20.500.12592/5xm12c

Initial treatment of community-acquired pneumonia

14 Mar 2005

INITIAL TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA: THE EFFECT OF INCOME ON SITE OF CARE AND CHOICE OF TREATMENT. [...] Institute of Health Economics Working Paper 04-10 iv ACKNOWLEDGEMENTS The authors gratefully acknowledge the financial support provided by the Institute of Health Economics and the University of Alberta. [...] In addition, due to the limited role of fluoroquinolones in the treatment of CAP15 and concerns regarding inappropriate use of this class of agents30, we sought to further examine the individual use of restricted antibiotics. [...] The reliability and validity of the Manitoba Health databases have been previously reported.31-33 6. Institute of Health Economics Working Paper 04-10 Medical claims contain records of physician services provided in a variety of settings (e.g., office, hospital or personal care home) and include information related to the date, type and location of the service and to a single diagnosis reflecting [...] All patient variables were again entered into the model, with the addition of ‘study year’ because of considerable changes in the consumption of a number of antibiotic classes over the study period.
health antimicrobial resistance antibiotics chemicals communicable diseases medical economics medicine pharmaceuticals pneumonia risk health care disease prescription drugs therapy communicable disease comorbidity clinical trial fluoroquinolones pharmacy clinical medicine medicaid icd-9-cm healthcare policy emergency department health treatment medical drugs medication pharmaceutical chronic obstructive pulmonary disease community-acquired pneumonia clarithromycin

Authors

Carrie, Anita G

Pages
39
Published in
Canada

Related Topics

All